1877-1173
Published by: Elsevier
https://www.sciencedirect.com/bookseries/progress-in-molecular-biology-and-translational-science
| Discipline name | Position | Best Scientists | Publications | D-Index |
|---|---|---|---|---|
| Molecular Biology | 180 | 6 | 6 | 3 |
| Biology and Biochemistry | 404 | 45 | 50 | 16 |
The journal aims to foster the development of research in Cell biology, Neuroscience, Disease, Computational biology and Genetics. Receptor and Cell are some topics wherein Cell biology research discussed in Progress in Molecular Biology and Translational Science have an impact. It focused on Disease research but expanded to cover Bioinformatics.
The concepts on Computational biology presented in the journal can also apply to other research fields, including Genome editing, Genome and CRISPR. The majority of CRISPR studies in it are focused on the subject of Cas9. Gene, Epigenetics and DNA methylation are all areas of Genetics tackled in it.
The journal papers mainly tackle studies in Cell biology, Neuroscience, Biochemistry, Genetics and Internal medicine. The published articles focus on Cell biology as well as the interrelated topics of Cadherin. The works on Neuroscience tackled in the journal articles bring together disciplines like Synaptic plasticity, Anesthesia and Disease.
The journal mainly deals with areas of study such as Computational biology, CRISPR, Genome editing, Cas9 and Gene. While Computational biology is the focus of it, it also provided insights into the studies of Function (biology), Regulation of gene expression, Intrinsically disordered proteins, Epigenetics and DNA sequencing. The research on CRISPR featured in the journal combines topics in other fields like Genome and Disease.
It explores topics in Disease which can be helpful for research in disciplines like Clinical trial, Neuroscience and Genetic testing. The studies in Transcription activator-like effector nuclease under the umbrella field of Genome editing overlap with concepts in Mechanism (biology). Progress in Molecular Biology and Translational Science explores research in Gene alongside concepts in Drug discovery and other areas of study in Genetic Medicine and Gene knockout.
A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.
The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.
The top authors publishing in Progress in Molecular Biology and Translational Science (based on the number of publications) are:
The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.
Only papers with recognized affiliations are considered
The top affiliations publishing in Progress in Molecular Biology and Translational Science (based on the number of publications) are:
The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.
The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.
The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.
During the most recent 2021 edition, 8.45% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 0.00% were posted by at least one author from the top 10 institutions publishing in the journal. Another 4.62% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 7.69% of all publications and 87.69% were from other institutions.
A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.
The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.
The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.
Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).
The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:
The chart below illustrates experience levels of first authors in cases of publications with multiple authors.
Pushpendra Mani Mishra;Navneet Chandra Verma;Chethana Rao;Vladimir N. Uversky
(2020)Megan S. Kennedy;Eugene B. Chang
(2020)Mahmoud Abdellatif;Senka Ljubojevic-Holzer;Frank Madeo;Simon Sedej;Simon Sedej
(2020)Anukool A Bhopatkar;Vladimir N Uversky;Vijayaraghavan Rangachari
(2020)Chelsea J Webber;Shuwen Eric Lei;Benjamin Wolozin
(2020)Sergi Ferré;Francisco Ciruela;Vicent Casadó;Leonardo Pardo
(2020)Gianluigi Forloni;Pietro La Vitola;Milica Cerovic;Claudia Balducci
(2021)Matthew Silbergleit;Adrian A. Vasquez;Carol J. Miller;Jun Sun
(2020)Gemma G Martínez-García;Guillermo Mariño
(2020)Tamás Csizmadia;Gábor Juhász;Gábor Juhász
(2020)Studying Biology and Biochemistry in the USA opens doors to numerous interdisciplinary fields. For students interested in mental health, pursuing a masters child and adolescent mental health can be a rewarding career path. This degree offers specialized knowledge to support younger populations, blending biology with psychology for comprehensive care.
Another relevant option is an online counseling degree, which complements a biology background by preparing graduates for roles that focus on emotional and behavioral well-being. This flexible path supports those wanting to impact mental health without leaving the life sciences behind.
For students aiming to enter the healthcare sector with a leadership focus, the cheapest online healthcare administration degree provides essential skills in managing healthcare facilities and services. This degree pairs well with biochemistry and biology knowledge, particularly in hospitals or biotech companies.
Finally, exploring jobs with a biology degree reveals a broad spectrum of high-paying roles, from research and pharmaceuticals to environmental science. Combining your scientific expertise with additional online training can maximize your impact and career options.
